(S)-4-Amino-3-(4-fluorophenyl)butanoic acid is a chiral, non-proteinogenic amino acid derivative. It features a 4-fluorophenyl group and a butanoic acid backbone with an amino group at the gamma position, making it a valuable β-amino acid analog. This compound serves as a crucial chiral building block in pharmaceutical synthesis. Its primary application is as a key intermediate in the production of potent dipeptidyl peptidase-4 (DPP-4) inhibitors, a major class of drugs for treating type 2 diabetes. Specifically, it is used in the synthesis of active pharmaceutical ingredients (APIs) such as sitagliptin and other gliptin-class medications. The (S)-configuration of the chiral center is essential for the desired biological activity of the final drug molecule. As a bifunctional molecule containing both a carboxylic acid and a primary amine, it is amenable to further chemical modifications, facilitating its incorporation into more complex molecular architectures. Its synthesis and use are subjects of patents and research focused on efficient, stereoselective production routes for diabetes therapeutics.